Literature DB >> 27413116

The Paradox of p53: What, How, and Why?

Yael Aylon1, Moshe Oren1.   

Abstract

Unlike the rather stereotypic image by which it was portrayed until not too many years ago, p53 is now increasingly emerging as a multifaceted transcription factor that can sometimes exert opposing effects on biological processes. This includes pro-survival activities that seem to contradict p53's canonical proapoptotic features, as well as opposing effects on cell migration, metabolism, and differentiation. Such antagonistic bifunctionality (balancing both positive and negative signals) bestows p53 with an ideal attribute to govern homeostasis. The molecular mechanisms underpinning the paradoxical activities of p53 may be related to a protein conformational spectrum (from canonical wild-type to "pseudomutant"), diversity of DNA response elements, and/or higher-order chromatin configuration. Altogether, this functional flexibility positions p53 as a transcriptional "super hub" that dictates cell homeostasis, and ultimately cell fate, by governing a hierarchy of other functional hubs. Deciphering the mechanisms by which p53 determines which hubs to engage, and how one might modulate the preferences of p53, remains a major challenge for both basic science and translational cancer medicine.
Copyright © 2016 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27413116      PMCID: PMC5046691          DOI: 10.1101/cshperspect.a026328

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  156 in total

1.  Tumor suppressor p53 and its homologue p73alpha affect cell migration.

Authors:  Anna A Sablina; Peter M Chumakov; Boris P Kopnin
Journal:  J Biol Chem       Date:  2003-05-15       Impact factor: 5.157

2.  A model for p53-induced apoptosis.

Authors:  K Polyak; Y Xia; J L Zweier; K W Kinzler; B Vogelstein
Journal:  Nature       Date:  1997-09-18       Impact factor: 49.962

3.  AMP-activated protein kinase induces a p53-dependent metabolic checkpoint.

Authors:  Russell G Jones; David R Plas; Sara Kubek; Monica Buzzai; James Mu; Yang Xu; Morris J Birnbaum; Craig B Thompson
Journal:  Mol Cell       Date:  2005-04-29       Impact factor: 17.970

4.  p53 mutant mice that display early ageing-associated phenotypes.

Authors:  Stuart D Tyner; Sundaresan Venkatachalam; Jene Choi; Stephen Jones; Nader Ghebranious; Herbert Igelmann; Xiongbin Lu; Gabrielle Soron; Benjamin Cooper; Cory Brayton; Sang Hee Park; Timothy Thompson; Gerard Karsenty; Allan Bradley; Lawrence A Donehower
Journal:  Nature       Date:  2002-01-03       Impact factor: 49.962

5.  p53 Activation in adipocytes of obese mice.

Authors:  Naoya Yahagi; Hitoshi Shimano; Takashi Matsuzaka; Yuho Najima; Motohiro Sekiya; Yoshimi Nakagawa; Tomohiro Ide; Sachiko Tomita; Hiroaki Okazaki; Yoshiaki Tamura; Yoko Iizuka; Ken Ohashi; Takanari Gotoda; Ryozo Nagai; Satoshi Kimura; Shun Ishibashi; Jun-Ichi Osuga; Nobuhiro Yamada
Journal:  J Biol Chem       Date:  2003-05-06       Impact factor: 5.157

6.  Regulation of autophagy by cytoplasmic p53.

Authors:  Ezgi Tasdemir; M Chiara Maiuri; Lorenzo Galluzzi; Ilio Vitale; Mojgan Djavaheri-Mergny; Marcello D'Amelio; Alfredo Criollo; Eugenia Morselli; Changlian Zhu; Francis Harper; Ulf Nannmark; Chrysanthi Samara; Paolo Pinton; José Miguel Vicencio; Rosa Carnuccio; Ute M Moll; Frank Madeo; Patrizia Paterlini-Brechot; Rosario Rizzuto; Gyorgy Szabadkai; Gérard Pierron; Klas Blomgren; Nektarios Tavernarakis; Patrice Codogno; Francesco Cecconi; Guido Kroemer
Journal:  Nat Cell Biol       Date:  2008-05-04       Impact factor: 28.824

7.  p53Ψ is a transcriptionally inactive p53 isoform able to reprogram cells toward a metastatic-like state.

Authors:  Serif Senturk; Zhan Yao; Matthew Camiolo; Brendon Stiles; Trushar Rathod; Alice M Walsh; Alice Nemajerova; Matthew J Lazzara; Nasser K Altorki; Adrian Krainer; Ute M Moll; Scott W Lowe; Luca Cartegni; Raffaella Sordella
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-29       Impact factor: 11.205

8.  Loss of p53 induces tumorigenesis in p21-deficient mesenchymal stem cells.

Authors:  Rene Rodriguez; Ruth Rubio; Manuel Masip; Purificación Catalina; Ana Nieto; Teresa de la Cueva; Mar Arriero; Nuria San Martin; Ernesto de la Cueva; Dimitrios Balomenos; Pablo Menendez; Javier García-Castro
Journal:  Neoplasia       Date:  2009-04       Impact factor: 5.715

9.  p53 regulates myogenesis by triggering the differentiation activity of pRb.

Authors:  A Porrello; M A Cerone; S Coen; A Gurtner; G Fontemaggi; L Cimino; G Piaggio; A Sacchi; S Soddu
Journal:  J Cell Biol       Date:  2000-12-11       Impact factor: 10.539

10.  Osteoblast differentiation and skeletal development are regulated by Mdm2-p53 signaling.

Authors:  Christopher J Lengner; Heather A Steinman; James Gagnon; Thomas W Smith; Janet E Henderson; Barbara E Kream; Gary S Stein; Jane B Lian; Stephen N Jones
Journal:  J Cell Biol       Date:  2006-03-13       Impact factor: 10.539

View more
  30 in total

1.  Prosurvival long noncoding RNA PINCR regulates a subset of p53 targets in human colorectal cancer cells by binding to Matrin 3.

Authors:  Ritu Chaudhary; Berkley Gryder; Wendy S Woods; Murugan Subramanian; Matthew F Jones; Xiao Ling Li; Lisa M Jenkins; Svetlana A Shabalina; Min Mo; Mary Dasso; Yuan Yang; Lalage M Wakefield; Yuelin Zhu; Susan M Frier; Branden S Moriarity; Kannanganattu V Prasanth; Pablo Perez-Pinera; Ashish Lal
Journal:  Elife       Date:  2017-06-05       Impact factor: 8.140

2.  p53 regulates its own expression by an intrinsic exoribonuclease activity through AU-rich elements.

Authors:  Sanaz Derech-Haim; Yael Friedman; Amnon Hizi; Mary Bakhanashvili
Journal:  J Mol Med (Berl)       Date:  2020-02-04       Impact factor: 4.599

3.  Regulation of the p53 expression profile by hnRNP K under stress conditions.

Authors:  Agata Swiatkowska; Mariola Dutkiewicz; Piotr Machtel; Damian M Janecki; Martyna Kabacinska; Paulina Żydowicz-Machtel; Jerzy Ciesiołka
Journal:  RNA Biol       Date:  2020-05-29       Impact factor: 4.652

4.  Investigating Conformational Dynamics and Allostery in the p53 DNA-Binding Domain Using Molecular Simulations.

Authors:  Elena Papaleo
Journal:  Methods Mol Biol       Date:  2021

Review 5.  The LATS1 and LATS2 tumor suppressors: beyond the Hippo pathway.

Authors:  Noa Furth; Yael Aylon
Journal:  Cell Death Differ       Date:  2017-06-23       Impact factor: 15.828

Review 6.  p53 shades of Hippo.

Authors:  Noa Furth; Yael Aylon; Moshe Oren
Journal:  Cell Death Differ       Date:  2017-10-06       Impact factor: 15.828

7.  Altered p53 functionality in cancer-associated fibroblasts contributes to their cancer-supporting features.

Authors:  Sharathchandra Arandkar; Noa Furth; Yair Elisha; Nishanth Belugali Nataraj; Heiko van der Kuip; Yosef Yarden; Walter Aulitzky; Igor Ulitsky; Benjamin Geiger; Moshe Oren
Journal:  Proc Natl Acad Sci U S A       Date:  2018-06-04       Impact factor: 11.205

Review 8.  The multiple mechanisms that regulate p53 activity and cell fate.

Authors:  Antonina Hafner; Martha L Bulyk; Ashwini Jambhekar; Galit Lahav
Journal:  Nat Rev Mol Cell Biol       Date:  2019-04       Impact factor: 94.444

9.  WDR63 inhibits Arp2/3-dependent actin polymerization and mediates the function of p53 in suppressing metastasis.

Authors:  Kailiang Zhao; Decai Wang; Xiaolong Zhao; Chenfeng Wang; Yongxiang Gao; Kaiyue Liu; Fang Wang; Xianning Wu; Xuejuan Wang; Linfeng Sun; Jianye Zang; Yide Mei
Journal:  EMBO Rep       Date:  2020-03-04       Impact factor: 8.807

Review 10.  Putting p53 in Context.

Authors:  Edward R Kastenhuber; Scott W Lowe
Journal:  Cell       Date:  2017-09-07       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.